AmpliTech Q2 Loss Widens 74% as Costs Surge; Material Weaknesses Persist
AMPG has more than doubled off its 52-week low of $1.64.
Summary
AmpliTech reported a wider Q2 loss on higher spending and lower revenue, while again flagging material weaknesses in financial reporting controls.
Key Events · Earnings and Guidance · AMPG
-
Q2 Net Loss Widens 74%
Net loss of $3.09M for Q2 2026 vs $1.77M in Q2 2025, driven by higher operating expenses.
-
Revenue Declines 27%
Revenue fell to $8.07M from $11.03M, though gross margin improved to 27.9% from 7.8%.
-
Material Weaknesses Persist
Management again concluded internal control over financial reporting was not effective due to previously identified material weaknesses.
-
Cash Position Remains Adequate
Cash and equivalents of $8.89M and working capital of $22.9M as of June 30, 2026.
Analysis · AMPG · Manufacturing
AmpliTech's Q2 2026 net loss widened to $3.09 million from $1.77 million a year earlier, driven by a 91% jump in SG&A and a 109% rise in R&D spending. Revenue fell 27% to $8.07 million, though gross margin improved to 27.9% from 7.8%. The company again disclosed material weaknesses in internal controls, a governance red flag that keeps the score elevated. Cash remains adequate at $8.9 million, and subsequent events—including a $21.9 million Series A Rights closing and a $10 million buyback—provide some offset, but the operating trajectory is deteriorating.
At the time of this filing, AMPG was trading at $4.96 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $151.8M. The 52-week trading range was $1.64 to $10.11. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.